Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor.

scientific article published on 13 October 2005

Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JTCVS.2005.07.012
P698PubMed publication ID16256783
P5875ResearchGate publication ID7509756

P50authorPaul W. FedakQ42732504
Ren-Ke LiQ50205349
Denis AngoulvantQ57243849
P2093author name stringRichard D Weisel
Liwen Chen
Terrence M Yau
Shafie Fazel
Jason Lam
Charit Seneviratne
Phillip Cheung
Amir Fazel
P2860cites workPluripotency of mesenchymal stem cells derived from adult marrowQ29617959
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1310
P577publication date2005-10-13
P1433published inThe Journal of Thoracic and Cardiovascular SurgeryQ2795598
P1476titleCell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor
P478volume130

Reverse relations

cites work (P2860)
Q50470562Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging.
Q37194005Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.
Q38858359Brain mesenchymal stem cells: physiology and pathological implications
Q37253735Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease
Q37319214Cardiogenic differentiation and transdifferentiation of progenitor cells
Q36296844Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression
Q55306317Chaihulonggumulitang Shows Psycho-cardiology Therapeutic Effects on Acute Myocardial Infarction by Enhancing Bone Marrow Mesenchymal Stem Cells Mobilization.
Q52714544Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior.
Q51812371Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function.
Q51545509Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN.
Q45864109Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Q38808728Gene therapy as a potential tool for treating neuroblastoma-a focused review
Q41120104Homing of stem cells to ischemic myocardium
Q26774939How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?
Q53438967Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation.
Q61805663In Vivo Response of Acellular Porcine Pericardial for Tissue Engineered Transcatheter Aortic Valves
Q45873510Inhibiting matrix metalloproteinase by cell-based timp-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy.
Q36056155Mesenchymal stem cells for cardiac regeneration: translation to bedside reality
Q37884436Mesenchymal stem cells for cardiovascular regeneration
Q46075392MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction
Q53922172Modulation of Alloimmune Responses by Interleukin-10 Prevents Rejection of Implanted Allogeneic Smooth Muscle Cells and Restores Postinfarction Ventricular Function.
Q84435159Panoramic view of the Fifth International Symposium on Stem Cell Therapy and Applied Cardiovascular Biotechnology, April 2008, Madrid (Spain)
Q36804591Realizing the cardiac stem cell promise: a case for trophism
Q36462071Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells
Q35002029Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine
Q36837256Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells.
Q27026285Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration
Q37544884Stem cell therapy for cardiac repair: benefits and barriers
Q53521178TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
Q92394700The Role of Extracellular Vesicles as Paracrine Effectors in Stem Cell-Based Therapies
Q26991746Therapeutic potential of mesenchymal stem cells for oral and systemic diseases
Q51761518Young Bone Marrow Sca-1 Cells Rejuvenate the Aged Heart by Promoting Epithelial-to-Mesenchymal Transition.

Search more.